Compare XBIT & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIT | GROY |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8M | 618.6M |
| IPO Year | 2015 | 2020 |
| Metric | XBIT | GROY |
|---|---|---|
| Price | $2.29 | $2.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.90 |
| AVG Volume (30 Days) | 35.1K | ★ 1.8M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $145.80 |
| Revenue Next Year | N/A | $60.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $2.37 |
| 52 Week High | $3.61 | $5.45 |
| Indicator | XBIT | GROY |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 36.70 |
| Support Level | $2.26 | N/A |
| Resistance Level | $2.42 | $3.86 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 15.61 | 15.00 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.